Literature DB >> 32565118

Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women.

Maria Brotons1, Laura Monfil2, Esther Roura3, Talita Duarte-Salles4, Jordi Casabona5, Luis Urbiztondo6, Carmen Cabezas7, F Xavier Bosch8, Silvia de Sanjosé9, Laia Bruni10.   

Abstract

Extensive multiple-age cohort human papillomavirus (HPV) vaccination has proved to be highly effective. We aimed to determine the 8-year population impact of a female single-age cohort HPV vaccination programme on the incidence of anogenital warts (AGW). In 2008, Catalonia initiated a school-based quadrivalent HPV vaccination programme targeting 11-year-old girls, achieving coverage over 80%. Data on diagnoses of AGW and genital herpes were obtained from a population-based database of electronic health records covering 74% of the population. The annual incidence rates from 2009 to 2016 were calculated, stratified by age and sex using Joinpoint regression to estimate trends and annual percentage changes (APC). Among women aged 16-19 years, the AGW incidence decreased by 61% from 2012 to 2016 (APC -19.4%; 95% CI: -30.0 to -7.3). In contrast, the incidence of genital herpes in same-aged women increased throughout the study period (APC 11.1%; 95% CI: 7.2-15.2). Among men aged 20-22 years, the increasing incidence of AGW shifted to a downward trend in 2013 (APC 2009-2013: 17.0%; 95% CI: 8.2-26.5; and APC 2013-2016: -4.5%; 95% CI: -14.6 to 6.9). A similar pattern was observed among men aged 23-25 years (APC 2009-2014: 16.0%; 95% CI: 12.0-20.2; and APC 2014-2016: -6.0%; 95% CI: -18.4 to 8.3). In contrast to AGW, among men aged 20-25 years, the incidence of genital herpes increased over this period. Our study strongly suggests that a single-cohort HPV vaccination strategy with high vaccine uptake not only provides direct benefit in the vaccinated cohorts but also extends protection through a herd effect to unvaccinated men.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anogenital warts; HPV; HPV vaccination; Impact; Incidence; Time trends

Mesh:

Substances:

Year:  2020        PMID: 32565118     DOI: 10.1016/j.ypmed.2020.106166

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  3 in total

1.  The pharmacist's role in prevention of HPV-related cancers.

Authors:  Vivien Brown; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2021-06-18

2.  On the Elimination of Infections Related to Oncogenic Human Papillomavirus: An Approach Using a Computational Network Model.

Authors:  Cintia Muñoz-Quiles; Javier Díez-Domingo; Luis Acedo; Víctor Sánchez-Alonso; Rafael J Villanueva
Journal:  Viruses       Date:  2021-05-13       Impact factor: 5.048

3.  Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain).

Authors:  Juan J Hernandez-Aguado; Damián Ángel Sánchez Torres; Esther Martínez Lamela; Gema Aguión Gálvez; Eva Sanz Espinosa; Almudena Pérez Quintanilla; Daniela A Martínez-Carrillo; Mar Ramírez Mena; Pluvio J Coronado Martín; Ignacio Zapardiel; Jesús de la Fuente-Valero
Journal:  Vaccines (Basel)       Date:  2022-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.